- Trimethoprim lactate
-
-
2026-09-11
- CAS:23256-42-0
- Min. Order: 1KG
- Purity: 98%min;CPV2015
- Supply Ability: 1000 KG
- Trimethoprim lactate
-
- $2.00
-
2026-08-25
- CAS:23256-42-0
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 100kg
|
| | Trimethoprim lactate salt Basic information |
| Product Name: | Trimethoprim lactate salt | | Synonyms: | lactic acid, compound with 5-(3,4,5-trimethoxybenzyl)pyrimidine-2,4-diamine (1:1);5-(3,4,5-triMethoxybenzyl)pyriMidine-2,4-diaMine 2-hydroxypropanoate;Lactic triMethopriM;Trimethoprim lactate, >=99%;5-(3,4,5-Trimethoxybenzyl);pyrimidine-2,4-diamine 2-hydroxypropanoate;2,4-DIAMINO-5-(3,4,5-TRIMETHOXYBENZYL)PYRIMIDINE LACTATE;2,4-diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine lactate salt | | CAS: | 23256-42-0 | | MF: | C17H24N4O6 | | MW: | 380.4 | | EINECS: | 245-533-1 | | Product Categories: | | | Mol File: | 23256-42-0.mol |  |
| | Trimethoprim lactate salt Chemical Properties |
| Melting point | 170 - 172°C | | storage temp. | Keep in dark place,Inert atmosphere,2-8°C | | solubility | H2O: soluble20mg/mL | | form | powder | | color | white | | Water Solubility | Soluble in water | | InChI | InChI=1S/C14H18N4O3.C3H6O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15;1-2(4)3(5)6/h5-7H,4H2,1-3H3,(H4,15,16,17,18);2,4H,1H3,(H,5,6) | | InChIKey | IIZVTUWSIKTFKO-UHFFFAOYSA-N | | SMILES | C(O)(C)C(=O)O.C(C1=CN=C(N)N=C1N)C1C=C(OC)C(OC)=C(OC)C=1 | | CAS DataBase Reference | 23256-42-0(CAS DataBase Reference) |
| Hazard Codes | T | | Risk Statements | 23/24/25-43-61 | | Safety Statements | 22-36/37/39-45-53 | | RIDADR | UN 2811 | | WGK Germany | 3 | | HazardClass | 6.1(b) | | PackingGroup | III | | Storage Class | 6.1C - Combustible acute toxic Cat.3
toxic compounds or compounds which causing chronic effects | | Hazard Classifications | Acute Tox. 3 Oral
Repr. 2 |
| | Trimethoprim lactate salt Usage And Synthesis |
| Chemical Properties | Crystalline | | Uses | Trimethoprim lactate salt is an antibacterial agent. | | Biological Activity | The combination of trimethoprim and sulfamethoxazole interferes with the cellular metabolism of folic acid in the bacterial cell by blocking the biosynthesis of nucleotides. Trimethoprim binds to prokaryote-specific dihydrofolate reductase (DHFR) and inhibits the reduction of dihydrofolic acid (DHF) to tetrahydrofolic acid (THF). THF is an essential precursor in the thymidine synthesis pathway and interference with this pathway inhibits bacterial DNA synthesis. |
| | Trimethoprim lactate salt Preparation Products And Raw materials |
|